Falsified medicines affect public health all around the globe. Complex distribution routes,
illegal online webshops and reuse of packaging materials make them hard to detect. In …

Abstract Background Universal Health Coverage (UHC) is challenged by the prevalence of
poor-quality medicines, those that either do not meet required specifications (substandard) …

The use of substandard and counterfeit medicines (SCM) leads to significant health and
economic consequences, like treatment failure, rise of antimicrobial resistance, extra …

Substandard and falsified medicines present a serious threat to public health. Simple, low-
cost screening tools are important in the identification of such products in low-and middle …

Background Quality issues in pharmaceuticals are identified as a huge global and public
health problem, especially with reference to low-and middle-income countries like Pakistan …

In recent decades, more than 15% of the antimalarials marketed in low-and middle-income
countries have been of poor quality, in which quinoline derivatives and quinine-based …

Substandard and falsified (SF) medicines are a global health challenge with the World
Health Organization (WHO) estimating that 1 in 10 of medicines in low-and middle-income …

Abstract Machine learning algorithms, and artificial intelligence in general, have a wide
range of applications in the field of pharmaceutical technology. Starting from the formulation …

Many life-saving drugs are still inaccessible and unaffordable in low-and middle-income
countries, particularly in Sub-Saharan Africa. This contributes to poor health outcomes …

Introduction Substandard medicines are medicines that fail to meet their quality standards
and/or specifications. Substandard medicines can lead to serious safety issues affecting …